Ferozsons Laboratories Limited (PSX:FEROZ)

Market Cap	18.11B
Revenue (ttm)	20.27B
Net Income (ttm)	814.84M
Shares Out	43.47M
EPS (ttm)	18.74
PE Ratio	22.22
Forward PE	n/a
Dividend	4.00 (0.98%)
Ex-Dividend Date	Oct 16, 2025

Volume	5,360
Average Volume	63,989
Open	414.00
Previous Close	410.01
Day's Range	407.02 - 422.00
52-Week Range	242.33 - 464.00
Beta	0.33
RSI	61.88
Earnings Date	Feb 16, 2026

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 1,556
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: FEROZ

Financial Performance

In 2025, Ferozsons Laboratories's revenue was 18.86 billion, an increase of 18.94% compared to the previous year's 15.85 billion. Earnings were 776.54 million, an increase of 13.67%.